The Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM, will host two news briefings on top head and neck cancer research from its meeting January 26-28, 2012, in Phoenix.
What:Two audio news briefing from the Multidisciplinary Head and Neck Cancer Symposium. (Audio recordings and slides are available after the news briefings on ASTRO's website.)
When: Thursday, January 26, 2012, at 7:00 a.m. Mountain time (9:00 a.m. Eastern time)
Study findings previewed:
•Oral HPV infection, HPV-related cancers more common in men
•Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer
•Standard treatments for head and neck cancer less effective in HIV-positive patients
How: Register for the webcast at https://astro.webex.com/astro/j.php?ED=135767347&RG=1&UID=0&RT=MiM1. You will receive a confirmation email with instructions for joining the meeting.
The webcast will prompt you to give a phone number for it to call you directly or give you the option to listen using VOIP.
When:Friday, January 27, 2012, at 7:00 a.m. Mountain time (9:00 a.m. Eastern time)
Study findings previewed:
•Danish health care fast track program reduces cancer patients' treatment, diagnosis wait time
•Newer radiation technology improves head and neck cancer patients' long-term quality of life
•Routine follow-up scans can detect head and neck cancer recurrences earlier
How: Register for the webcast at https://astro.webex.com/astro/j.php?ED=135767162&RG=1&UID=0&RT=MiM1. You will receive a confirmation email with instructions for joining the meeting.
The webcast will prompt you to give a phone number for it to call you directly or give you the option to listen using VOIP.
Breakthrough imaging method enhances precision in prostate cancer treatment